Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBB.1.16.24EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.17EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DV.7.1.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DV.7.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JP.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XCT.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.15EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GS.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FY.5.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FE.1.1.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.20EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GK.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.14EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDD.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KR.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
MD.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDD.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.64.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDP.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KR.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KZ.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KS.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.19EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.47EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.23EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.4.2.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LK.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDSEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LY.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDQ.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.18EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GJ.1.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.3.2.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GW.5.3.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.23.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JE.1.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.83EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.32EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HN.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.13EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.310EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.185EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.258.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.329EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.229EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.342EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.90EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.169EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used